As of 2024-12-14, the Relative Valuation of Aerie Pharmaceuticals Inc (AERI) is (21.60) USD. This relative valuation is based on P/E multiples. With the latest stock price at 15.25 USD, the upside of Aerie Pharmaceuticals Inc based on Relative Valuation is -241.6%.
The range of the Relative Valuation is (20.33) - (21.69) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 27.1x - 30.8x | 29.2x |
| Forward P/E multiples | 27.5x - 29.3x | 29.2x |
| Fair Price | (20.33) - (21.69) | (21.60) |
| Upside | -233.3% - -242.2% | -241.6% |
| Date | P/E |